From the Journals

The psychopathic brain: New insight


 

Structural brain differences appear to distinguish psychopaths from individuals without psychopathic traits, new research shows.

Using MRI, researchers found that the striatum was about 10% larger on average in adults with psychopathic traits than in matched control persons and that this relationship was mediated by stimulation seeking and impulsivity.

The striatum is a subcortical region of the forebrain involved in the cognitive processing of reward-related information and motivational aspects of behavior.

“Our study’s results help advance our knowledge about what underlies antisocial behavior such as psychopathy,” co-author and neurocriminologist Olivia Choy, PhD, with Nanyang Technological University, Singapore, said in a news release.

“In addition to social environmental influences, it is important to consider that there can be differences in biology – in this case, the size of brain structures – between antisocial and non-antisocial individuals,” Dr. Choy added.

The study was published online in the Journal of Psychiatric Research.

Antisocial, egocentric

Individuals with psychopathic traits typically have an egocentric and antisocial personality. They generally lack remorse for their actions or empathy for others and often have criminal tendencies.

Some prior research suggests links between psychopathy and an overactive striatum, but it was unclear what role striatal volume plays in this behavior.

For the study, investigators assessed striatal volume using MRI in 120 adults living in the community, and they assessed psychopathy using the Psychopathy Checklist – Revised.

Correlational analyses showed that increased striatal volumes were associated with more psychopathic traits (P = .001) in both men and women.

Volumetric increases were found for all subregions of the striatum in psychopathic individuals, after controlling for age, substance dependence, substance abuse, antisocial personality disorder, attention-deficit/hyperactivity disorder, social adversity, and total brain volume.

An analysis of 18 psychopathic individuals showed that striatal volumes were increased 9.4%, compared with 18 propensity-matched control persons (P = .01).

Abnormal reward processing

Stimulation seeking and impulsivity partly mediated the striatal-psychopathy relationship, accounting for 49.4% of this association.

These findings “replicate and build on initial studies indicating striatal enlargement in adults with psychopathy, yielding an updated effect size of d = 0.48,” the researchers note.

The results are “consistent with the notion that striatal abnormalities in individuals with psychopathy partly reflect increased sensation-seeking and impulsivity and support the hypothesis of abnormal reward processing in psychopathy,” they add.

Dr. Adrian Raine

“We have always known that psychopaths go to extreme lengths to seek out rewards, including criminal activities that involve property, sex, and drugs,” co-author Adrian Raine, DPhil, department of criminology, psychiatry, and psychology, University of Pennsylvania, Philadelphia, said in a news release.

“We are now finding out a neurobiological underpinning of this impulsive and stimulating behavior in the form of enlargement to the striatum, a key brain area involved in rewards,” Dr. Raine added.

What causes striatal enlargement in individuals with psychopathy still needs to be determined.

In human development, the striatum typically becomes smaller as a child matures, suggesting that psychopathy is associated with differences in brain development, the researchers suggest.

“Because biological traits, such as the size of one’s striatum, can be inherited to child from parent, these findings give added support to neurodevelopmental perspectives of psychopathy – that the brains of these offenders do not develop normally throughout childhood and adolescence,” said Dr. Raine.

Pages

Recommended Reading

Mental illness tied to COVID-19 breakthrough infection
MDedge Psychiatry
New combination med for severe mental illness tied to less weight gain
MDedge Psychiatry
High antipsychotic switch rates suggest ‘suboptimal’ prescribing for first-episode psychosis
MDedge Psychiatry
Virtual reality therapy promising for agoraphobia
MDedge Psychiatry
Cats, toxoplasmosis, and psychosis: Understanding the risks
MDedge Psychiatry
Higher ‘chemical restraint’ rates in Black psych patients in the ED
MDedge Psychiatry
Do psychotropic meds raise or lower COVID risk in psych patients?
MDedge Psychiatry
New data support electroconvulsive therapy for severe depression
MDedge Psychiatry
Clozapine and cancer risk in schizophrenia patients: New data
MDedge Psychiatry
Neuropsychiatric risks of COVID-19: New data
MDedge Psychiatry